Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42156669

Ashraf Hassanien; Basem M Alraddadi; Burcu Karakuzu Ikizler; Florence Lefebvre d'Hellencourt; Giovanni Zanotti; Haridy Hammam; Júlia Regazzini Spinardi; Lu Wang; Moe H Kyaw; Mohamed Kamal; Mohammad Bosaeed; Reem S Almaghrabi

May 20, 2026